MANKIND.NS
MANKIND.NS
INE634S01028
MANKIND PHARMA LIMITED
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 142.776.400.000 122.074.400.000
17.0%
Cost of Revenue 41.495.800.000 35.691.800.000
16.3%
Gross Profit 101.280.600.000 86.382.600.000
17.2%
72.929.900.000 61.221.100.000
19.1%
Operating Income 28.350.700.000 25.161.500.000
12.7%
Pretax Income 23.326.800.000 25.163.300.000
7.3%
Net Income Common Stockholders 19.129.300.000 19.909.600.000
3.9%
-- --
--
-- --
--
ende